The Trump administration just signed a new executive order dialing back federal restrictions on marijuana. It's one of those policy moves that sounds niche on the surface but actually signals something bigger about how Washington's rethinking drug policy—and by extension, regulatory approach more broadly.

When you step back, this kind of policy loosening in the US tends to ripple through sentiment around alternative sectors and emerging markets. Whether it reshapes institutional investment flows or just shifts how investors think about risk and government intervention... that's worth watching. The signal here isn't just about cannabis. It's about the administration's stance on which industries get unburdened from federal red tape.